Medical Devices News

MDR Annex XVI

Annex XVI of EU MDR 2017/745 covers specific product groups that do not have a medical intended purpose, yet are used on the human body and inherently carry certain risks. Although these products are not intended for diagnosis or treatment, they are included within the MDR framework due to their potential impact on human health and safety.

a young doctor conducting tests under a microscope

Kiwa joins RAPS Europe 2026

From 5 to 8 May 2026, Lisbon will host a new edition of RAPS Europe, one of the leading European events dedicated to Regulatory Affairs in the life sciences and medical devices sector.

Kiwa participates in the EU Commission High-Level Conference on Medical Devices

On 16 March 2026, the European Commission hosted the High-Level Conference on Medical Devices: Innovation and Patient Safety in Brussels, an event that brought together key institutional representatives, regulatory authorities, industry experts, and stakeholders from across Europe.

CBTL scope extension Electrical safety testing

A practical view on MDR and its challenges

Since the introduction of MDR (EU) 2017/745, many manufacturers describe the regulation as demanding and time-intensive. And while MDR is thorough by design, many of the hurdles companies face stem from fragmented processes rather than the regulation itself.

Navigating conformity assessment routes in the MDR.

Under Article 52 and Annexes IX through XI of the Medical Device Regulation (MDR), it is the legal manufacturer's responsibility to select the appropriate conformity assessment route. However, as a Notified Body, we often observe confusion regarding what these assessments entail and which route is best. The correct choice depends on the device classification and the level of control the manufacturer maintains over design and production.

Stack of white paper documents clipped together on a desk.

Why Timely Notification of Change Matters in Medical Device Certification

At Kiwa Assurance, we recognize that innovation is a constant in the medical device industry. But change comes with responsibility—especially when it comes to maintaining compliance under the MDR and ISO 13485. That’s where our Notification of Change (NoC) process plays a vital role.

Impact of the AI-act on your medical device

Any medical device that makes use of software, or is a software in itself (MDSW), could potentially fall under the Regulation 2024/1689 (informally known as ‘AI act’), if the software, or part of it, meets the definition as laid down in this Regulation*. For devices falling under the AI Act, the deadline of August 2, 2027, is fast approaching, considering the timelines for conformity assessment.  

Article

Overview of AI-Enabled SaMD and SiMD Devices

Artificial Intelligence (AI)-based software medical devices are revolutionizing the healthcare sector in diagnosis, treatment, and patient management. AI-powered Software as a Medical Device (SaMD) and Software in a Medical Device (SiMD) applications cover a wide range of solutions, from medical decision support systems to patient monitoring tools.

Medical equipment close-up in a healthcare facility, displaying vital signs on a monitor, with healthcare professionals in scrubs and masks in the background

Medical Devices

Medical devices manufactured or traded in the EU must comply with EU legislation in safety and health. This means they must be conformed to the pertaining product directives and regulations and must be CE marked.

Stay Connected with Kiwa Medical

Follow our Kiwa Medical showcase on LinkedIn for the latest updates on healthcare standards, certifications, and innovations. Join the conversation and stay informed!

Contact us

Would you like to know more about our services in the field of Medical devices? Please contact us using this form.